• Pharma
  • October 17, 2018
  • 208 views
Piramal weighs $1bn contract pharma sale

Billionaire Ajay Piramal is considering a sale of his contract pharmaceutical operations, which could fetch around $1 billion, people with knowledge of the matter said. The tycoon’s Piramal Enterprises is…

  • Pharma
  • October 12, 2018
  • 214 views
Trevena’s opioid painkiller fails to get FDA panel backing

By Saumya Joseph and Ankur Banerjee Trevena Inc’s opioid injection for managing acute pain failed to win the backing of an advisory panel to the Food and Drug Administration on…

  • Pharma
  • October 12, 2018
  • 230 views
CHENNAI: State to spend Rs 35 lakh more for common drug

CHENNAI: The state health department will soon have to spend about Rs 35 lakh more a month for a commonly used drug in labour rooms of government hospitals following the…

  • Pharma
  • October 12, 2018
  • 209 views
Walgreens revenue hit by weakness in personal care products, OTC drugs

By Manas Mishra Walgreens Boots Alliance Inc came up short of analysts’ estimates for quarterly revenue on Thursday, as sales of personal care products and over-the-counter drugs fell both in…

  • Pharma
  • October 12, 2018
  • 174 views
UP to open 6 pharma parks; gets Rs 5,000-6,000 cr commitment

The Uttar Pradesh government is planning to open six pharma parks across the state and has received an investment commitment of about Rs 5,000-6,000 crore from domestic and multinational pharma…

  • Pharma
  • October 10, 2018
  • 155 views
China approves 17 anti-cancer drugs for medical insurance coverage

SHANGHAI: China has approved 17 anti-cancer drugs for inclusion in its national health insurance system, the government said on Wednesday, part of its efforts to make cancer treatment more affordable…

  • Pharma
  • October 9, 2018
  • 149 views
Affimed puts on hold cancer drug trial after patient death

Drug developer Affimed N.V. on Monday put on hold the testing of its experimental cancer drug following the death of a patient and two life-threatening events. The company’s shares slumped…

  • Pharma
  • October 6, 2018
  • 140 views
Akcea Therapeutics genetic disease treatment gets FDA approval

Akcea Therapeutics Inc said on Friday its treatment, developed along with Ionis Pharmaceuticals , which targets a rare genetic disease was approved by the U.S. Food and Drug Administration. Akcea’s…

  • Pharma
  • October 4, 2018
  • 162 views
Govt relaxes import norms for certain chemicals used in pharma sector

New Delhi: The government Wednesday relaxed import norms for about 34 chemicals used in pharmaceuticals industry, a move which would ease inbound shipments of these items. The import policy of…

  • Pharma
  • October 4, 2018
  • 161 views
More than 500 lawsuits against acne drug maker are dismissed

TRENTON, N.J.: The maker of an acne drug that caused some patients to develop a gastrointestinal disease provided adequate warnings about the drug’s side effects, New Jersey’s Supreme Court ruled…